In an interview with “EWTN News Nightly” anchor Tracy Sabol, National Catholics Bioethics Center President Dr. Joseph Meaney discusses the first-ever therapy approved by the FDA using CRISPR, a genome editing technology. / Credit: “EWTN News Nig… […]
The research community, through embryo-destructive research, is intent on developing a new “therapy” that promises little to no health benefit for those suffering from disease. […]
Here is why only genetic engineers who understand and act from a classical virtue ethics are capable of adding moral ballast to the fast-moving ship […]
The temptation to use knowledge to break through the seemingly built-in limitations of the human condition, creating superheroes and making the world anew, has been […]
© Catholic World Report